Ultrasensitive dose-response for asbestos cancer risk implied by new inflammation-mutation model.

Area of Science:

• Cellular biology
• Molecular mechanisms of disease
• Cancer research

Background:

• Cellular phenotypes involve ultrasensitive molecular switches with nonlinear responses.
• Traditional cancer models, like the Moolgavkar-Venzon-Knudsen (MVK) model, often assume linear no-threshold (LNT) dose-response for genotoxic damage.
• Mesothelioma and lung cancer from asbestos exposure have ambiguous low-dose response expectations due to potential roles of mutation, inflammation, or both.

Conclusions:

• The ISM theory offers a new framework for understanding cancer initiation, emphasizing inflammation's active role.
• Understanding the mechanisms of inflammation resolution and how mutations impede it is critical for assessing risks of asbestos-related cancers.
• Further research into the specific molecular interactions proposed could elucidate low-dose response curves for these carcinogens.